Back
Veracyte 10K Form
Buy
83
VCYT
Veracyte
Last Price:
39.51
Seasonality Move:
6.55%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VCYT News And Ratings
See the #1 stock for the next 7 days that we like better than VCYT
VCYT Financial Statistics
Sales & Book Value
| Annual Sales: | $361.05M |
|---|---|
| Cash Flow: | $27.72M |
| Price / Cash Flow: | 53.18 |
| Annual Sales: | $15.18 |
| Price / Book: | 2.61 |
Profitability
| EPS (TTM): | -0.15000 |
|---|---|
| Net Income (TTM): | $-9.27M |
| Gross Margin: | $248.15M |
| Return on Equity: | -0.84% |
| Return on Assets: | -0.78% |
Veracyte Earnings Forecast
Key Veracyte Financial Ratios
- The Gross Profit Margin over the past 13 years for VCYT is 68.73%.
- The Selling, General & Administrative Expenses for VCYT have been equal to 51.03% of Gross Profit Margin.
- The Research & Development expenses have been 15.87% of Revenue.
- The Interest Expense is -0.02% of Operating Income.
- The Net Earning history of VCYT is -20.61% of Total Revenues.
- Per Share Earnings over the last 13 years have been positive in 7 years.
Veracyte Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VCYT |
| CUSIP: | 92337F |
| Website: | veracyte.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.08 |
| Quick Ratio: | 4.59 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 44.31 |